MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• MicroRNAs regulate gene expression by binding to mRNA 3'-UTRs.
• Protein Kinase C epsilon (PKCε) is involved in cell signaling and apoptosis.
• miR-146a is implicated in papillary thyroid carcinoma (PTC) and its expression is linked to NF-κB activation.

Purpose of the Study:

• To investigate the role of miR-146a in thyroid carcinoma.
• To determine if miR-146a suppresses PKCε expression and induces apoptosis in PTC cells.
• To explore the feedback mechanism of miR-146a within the NF-κB pathway in PTC.

Main Methods:

• Computational analysis to predict miR-146a binding to PRKCE 3'-UTR.
• Luciferase reporter assay to confirm direct binding.
• Overexpression of miR-146a in PTC cell lines (NPA-187) and subsequent analysis of PKCε levels and apoptosis.
• In vivo studies using tumor xenografts in mice.

Main Results:

• miR-146a directly binds to the PRKCE 3'-UTR.
• Overexpression of miR-146a significantly reduced PKCε levels and increased apoptosis in PTC cells.
• Tumor growth was significantly inhibited in vivo when using cells with stable miR-146a expression.
• miR-146a is involved in a negative feedback loop with the NF-κB pathway in PTC.

Conclusions:

• miR-146a acts as a tumor suppressor in thyroid carcinoma.
• Targeting PKCε by miR-146a modulates Ras/Raf-1 signaling and apoptosis in PTC.
• miR-146a plays a role in the NF-κB feedback system within PTC.